<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527475/" ref="ordinalpos=604&amp;ncbi_uid=4495137&amp;link_uid=PMC3527475" image-link="/pmc/articles/PMC3527475/figure/pone-0050638-g004/" class="imagepopup">Figure 4. Sal represses the Wnt/β-catenin <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> and increases intracellular calcium in vitro..  From: Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo. </a></div><br /><div class="p4l_captionBody">A. Real-time PCR was performed to examine mRNA expression of the Wnt pathway (DKK1, DKK2, GSK-3α, GSK-3β, and β-catenin), the hedgehog pathway (Gli-1, Patched, Shh, and Smo), the TGF-β pathway (TGF-β, Smad1, Smad2, Smad3, Smad4, Smad5, and Smad8), and growth factor receptor pathways (EGFR, VEGFR, AKT, and MAPK). Compared to control, the expression of β-catenin is significantly down-regulated (*p&lt;0.05). B. Sal inhibits Wnt/β-catenin signaling in HepG2, SMMC-7721, and BEL-7402 cells. p-GSK-3β, GSK-3β, and β-catenin expression were evaluated by Western blot.</div></div>